BlackRock Health Sciences Term Trust
 
 
 
 
基本資料
種類: ETF
費用比率%: 1.37
資產淨值: 19.01
成立日期: 29/01/2020
 
分析
市值分佈:
73.61%
大市值
6.05%
中市值
2.66%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 19/09/2026 05:40) 總持有投資項目: 114  
0%
 
100%
     10大 (25.53%)
代號 名稱 佔比% ▼ 持有日期
UTHRUnited Therapeutics Corp0.1630/06/2026
SRRKScholar Rock Holding Corp0.1530/06/2026
NUVBNuvation Bio0.1530/06/2026
KYMRKymera Therapeutics0.1530/06/2026
BCAXBicara Therapeutics Inc.0.1530/06/2026
UPBUpstream Bio Inc0.1531/12/2025
IMNMImmunome0.1430/06/2026
DSKYFDaiichi Sankyo Co., Ltd.0.1430/06/2026
MAZEMaze Therapeutics Inc0.1230/06/2026
EYPTEyePoint Inc.0.1030/06/2026
ORICOric Pharmaceuticals0.1030/06/2026
ABVXAbivax SA0.1031/03/2026
AKESFAKESO INC.0.1030/06/2026
BNTXBioNTech SE American Depositary Share0.1030/06/2026
ENTAEnanta Pharmaceuticals0.0931/03/2026
RGNXREGENXBIO0.0930/06/2026
SMMTSummit Therapeutics0.0930/06/2026
KODKodiak Sciences0.0831/03/2026
CTMXCytomX Therapeutics0.0830/06/2026
NGNENeurogene0.0831/03/2026
  1    2    3    4   5    6  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.